Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wendling

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Rheumatology (Oxford, England)|October 27, 1999
Rheumatic disorders developed after hepatitis B vaccinationJ F Maillefert, J Sibilia, E Toussirot, et al.
Arthritis Care & Research|June 12, 2013
Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registryS Godot, J-E Gottenberg, S Paternotte, et al.
The Journal of Rheumatology|October 21, 1998
Factors linked to disease activity in a French cohort of patients with spondyloarthropathyP Claudepierre, J Sibilia, F Roudot-Thoraval, et al.
Annals of the Rheumatic Diseases|May 13, 2014
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trialX Chevalier, P Ravaud, E Maheu, et al.
Annals of the Rheumatic Diseases|December 24, 2010
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registryD Salmon-Ceron, F Tubach, O Lortholary, et al.
Annals of the Rheumatic Diseases|July 5, 2005
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of RheumatologyX Le Loët, J M Berthelot, A Cantagrel, et al.
The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.
Arthritis Care & Research|November 15, 2011
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab RegistryX Puéchal, J E Gottenberg, J M Berthelot, et al.
Osteoarthritis and Cartilage|February 1, 2021
Effectiveness, safety, and cost-utility of a knee brace in medial knee osteoarthritis: the ERGONOMIE randomized controlled trialM Gueugnon, I Fournel, A-L Soilly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2015
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's SyndromeG Nocturne, A Virone, Wan-Fai Ng, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Rheumatology (Oxford, England)|October 27, 1999
Rheumatic disorders developed after hepatitis B vaccinationJ F Maillefert, J Sibilia, E Toussirot, et al.
Arthritis Care & Research|June 12, 2013
Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registryS Godot, J-E Gottenberg, S Paternotte, et al.
The Journal of Rheumatology|October 21, 1998
Factors linked to disease activity in a French cohort of patients with spondyloarthropathyP Claudepierre, J Sibilia, F Roudot-Thoraval, et al.
Annals of the Rheumatic Diseases|May 13, 2014
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trialX Chevalier, P Ravaud, E Maheu, et al.
Annals of the Rheumatic Diseases|December 24, 2010
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registryD Salmon-Ceron, F Tubach, O Lortholary, et al.
Annals of the Rheumatic Diseases|July 5, 2005
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of RheumatologyX Le Loët, J M Berthelot, A Cantagrel, et al.
The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.
Arthritis Care & Research|November 15, 2011
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab RegistryX Puéchal, J E Gottenberg, J M Berthelot, et al.
Osteoarthritis and Cartilage|February 1, 2021
Effectiveness, safety, and cost-utility of a knee brace in medial knee osteoarthritis: the ERGONOMIE randomized controlled trialM Gueugnon, I Fournel, A-L Soilly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2015
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's SyndromeG Nocturne, A Virone, Wan-Fai Ng, et al.
Pageof 19